VivaLNK Offers Wearable ECG Solution for 6MWT
VivaLNK has announced the availability of a wearable ECG monitoring solution designed to wirelessly capture ECG and heart rate during a six-minute walk test (6MWT).
The VivaLNK solution is used for clinical research in a variety of applications, such as cardiac rehab, digital biomarkers of arrhythmia onset, and pharmaceutical clinical trials, and includes a wearable ECG patch, a specialized mobile app, and cloud data services. In these studies, patients wear the wireless ECG patch while a clinician is able to monitor and control the test using a mobile app. Data collected during the test is then consolidated into a centralized database in the cloud for post analysis.
For more information, click here.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
